Utility of next-generation RNA-sequencing in identifying chimeric transcription involving human endogenous retroviruses

APMIS

Volumn 124, Issue 1-2, 2016, Pages 127-139

  Sokol, Martin ^a   Jessen, Karen Margrethe ^a   Pedersen, Finn Skou ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

CADM2; Chimeric transcription; Chromatin immunoprecipitation with sequencing (ChIP seq); CSF1R; Human endogenous retrovirus and endogenous retrovirus like repeats (HERVs); Integration mapping; LTR12 ERV9 LTR repeat; LTR2 FABP7; Paired end RNA sequencing (RNA seq); PRODH; SEMA3A; TP63; Tumor suppressor regulation; Unannotated transcription

Indexed keywords

HEMOGLOBIN BETA CHAIN; HEMOGLOBIN GAMMA CHAIN; RNA; SEMAPHORIN 3A; CADM2 PROTEIN, HUMAN; CELL ADHESION MOLECULE; ISOPROTEIN; SEMA3A PROTEIN, HUMAN; TP63 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

CELL LINE; CHIMERA; CHROMATIN IMMUNOPRECIPITATION; DNA DAMAGE; ENDOGENOUS RETROVIRUS; GENE CONTROL; GENE LOCUS; GENE MAPPING; GENETIC TRANSCRIPTION; GERM LINE; HEMATOPOIESIS; HUMAN; HUMAN GENOME; LONG TERMINAL REPEAT; MALE; NEXT GENERATION SEQUENCING; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; RETROVIRIDAE; REVIEW; RNA SEQUENCE; TESTIS; TUMOR SUPPRESSOR GENE; GENE EXPRESSION REGULATION; GENETICS; HIGH THROUGHPUT SEQUENCING; PROCEDURES; PROMOTER REGION; SEQUENCE ANALYSIS; STANDARDS;

CELL ADHESION MOLECULES; CHROMATIN IMMUNOPRECIPITATION; ENDOGENOUS RETROVIRUSES; GENE EXPRESSION REGULATION; GENOME, HUMAN; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALE; PROMOTER REGIONS, GENETIC; PROTEIN ISOFORMS; RNA; SEMAPHORIN-3A; SEQUENCE ANALYSIS, RNA; TERMINAL REPEAT SEQUENCES; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 84969373505     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/apm.12477     Document Type: Review

References (99)

1. Lokossou AG, Toudic C, Barbeau B. Implication of human endogenous retrovirus envelope proteins in placental functions. Viruses 2014;6:4609-27.
2. Kassiotis G. Endogenous retroviruses and the development of cancer. J Immunol 2014;192:1343-9.
3. Maksakova IA, Romanish MT, Gagnier L, Dunn CA, van de Lagemaat LN, Mager DL. Retroviral elements and their hosts: insertional mutagenesis in the mouse germ line. PLoS Genet 2006;2:e2.
4. Wolf G, Nielsen AL, Mikkelsen JG, Pedersen FS. Epigenetic marking and repression of porcine endogenous retroviruses. J Gen Virol 2013;94:960-70.
5. Berkhout B, Jebbink M, Zsiros J. Identification of an active reverse transcriptase enzyme encoded by a human endogenous HERV-K retrovirus. J Virol 1999;73:2365-75.
6. Dewannieux M, Blaise S, Heidmann T. Identification of a functional envelope protein from the HERV-K family of human endogenous retroviruses. J Virol 2005;79:15573-7.
7. Yang J, Bogerd HP, Peng S, Wiegand H, Truant R, Cullen BR. An ancient family of human endogenous retroviruses encodes a functional homolog of the HIV-1 Rev protein. Proc Natl Acad Sci USA 1999;96:13404-8.
8. Ruggieri A, Maldener E, Sauter M, Mueller-Lantzsch N, Meese E, Fackler OT, et al. Human endogenous retrovirus HERV-K(HML-2) encodes a stable signal peptide with biological properties distinct from Rec. Retrovirology 2009;6:17.
9. Muster T, Waltenberger A, Grassauer A, Hirschl S, Caucig P, Romirer I, et al. An endogenous retrovirus derived from human melanoma cells. Cancer Res 2003;63:8735-41.
10. Boller K, Konig H, Sauter M, Mueller-Lantzsch N, Lower R, Lower J, et al. Evidence that HERV-K is the endogenous retrovirus sequence that codes for the human teratocarcinoma-derived retrovirus HTDV. Virology 1993;196:349-53.
11. Sauter M, Roemer K, Best B, Afting M, Schommer S, Seitz G, et al. Specificity of antibodies directed against Env protein of human endogenous retroviruses in patients with germ cell tumors. Cancer Res 1996;56:4362-5.
12. Sauter M, Schommer S, Kremmer E, Remberger K, Dolken G, Lemm I, et al. Human endogenous retrovirus K10: expression of Gag protein and detection of antibodies in patients with seminomas. J Virol 1995;69:414-21.
13. Hohn O, Hanke K, Bannert N. HERV-K(HML-2), The best preserved family of HERVs: endogenization, expression, and implications in health and disease. Front Oncol 2013;3:246.
14. Lee YN, Bieniasz PD. Reconstitution of an infectious human endogenous retrovirus. PLoS Pathog 2007;3:e10.
15. Suntsova M, Gogvadze EV, Salozhin S, Gaifullin N, Eroshkin F, Dmitriev SE, et al. Human-specific endogenous retroviral insert serves as an enhancer for the schizophrenia-linked gene PRODH. Proc Natl Acad Sci USA 2013;110:19472-7.
16. Hughes JF, Coffin JM. Human endogenous retrovirus K solo-LTR formation and insertional polymorphisms: implications for human and viral evolution. Proc Natl Acad Sci USA 2004;101:1668-72.
17. Huh JW, Kim DS, Ha HS, Kim TH, Kim W, Kim HS. Formation of a new solo-LTR of the human endogenous retrovirus H family in human chromosome 21. Mol Cells 2006;22:360-3.
18. Uren AG, Kool J, Berns A, van Lohuizen M. Retroviral insertional mutagenesis: past, present and future. Oncogene 2005;24:7656-72.
19. Lamprecht B, Walter K, Kreher S, Kumar R, Hummel M, Lenze D, et al. Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma. Nat Med 2010;16:571-9, 1 p following 9.
20. Lock FE, Rebollo R, Miceli-Royer K, Gagnier L, Kuah S, Babaian A, et al. Distinct isoform of FABP7 revealed by screening for retroelement-activated genes in diffuse large B-cell lymphoma. Proc Natl Acad Sci USA 2014;111:E3534-43.
21. Beyer U, Moll-Rocek J, Moll UM, Dobbelstein M. Endogenous retrovirus drives hitherto unknown proapoptotic p63 isoforms in the male germ line of humans and great apes. Proc Natl Acad Sci USA 2011;108:3624-9.
22. Huh JW, Kim DS, Kang DW, Ha HS, Ahn K, Noh YN, et al. Transcriptional regulation of GSDML gene by antisense-oriented HERV-H LTR element. Arch Virol 2008;153:1201-5.
23. Sin HS, Huh JW, Kim DS, Kang DW, Min DS, Kim TH, et al. Transcriptional control of the HERV-H LTR element of the GSDML gene in human tissues and cancer cells. Arch Virol 2006;151:1985-94.
24. Mack M, Bender K, Schneider PM. Detection of retroviral antisense transcripts and promoter activity of the HERV-K(C4) insertion in the MHC class III region. Immunogenetics 2004;56:321-32.
25. Pi W, Zhu X, Wu M, Wang Y, Fulzele S, Eroglu A, et al. Long-range function of an intergenic retrotransposon. Proc Natl Acad Sci USA 2010;107:12992-7.
26. Dunn CA, Romanish MT, Gutierrez LE, van de Lagemaat LN, Mager DL. Transcription of two human genes from a bidirectional endogenous retrovirus promoter. Gene 2006;366:335-42.
27. Sokol M, Jessen K, Pedersen F. Human endogenous retroviruses sustain complex and cooperative regulation of gene-containing loci and unannotated megabase-sized regions. Retrovirology 2015;12:32.
28. Ling J, Pi W, Bollag R, Zeng S, Keskintepe M, Saliman H, et al. The solitary long terminal repeats of ERV-9 endogenous retrovirus are conserved during primate evolution and possess enhancer activities in embryonic and hematopoietic cells. J Virol 2002;76:2410-23.
29. Liu C, Morishima M, Jiang X, Yu T, Meng K, Ray D, et al. Engineered chromosome-based genetic mapping establishes a 3.7 Mb critical genomic region for Down syndrome-associated heart defects in mice. Hum Genet 2014;133:743-53.
30. Belichenko NP, Belichenko PV, Kleschevnikov AM, Salehi A, Reeves RH, Mobley WC. The "Down syndrome critical region" is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome. J Neurosci 2009;29:5938-48.
31. Du Y, Zhang J, Wang H, Yan X, Yang Y, Yang L, et al. Hypomethylated DSCR4 is a placenta-derived epigenetic marker for trisomy 21. Prenat Diagn 2011;31:207-14.
32. de Wit NJ, Cornelissen IM, Diepstra JH, Weidle UH, Ruiter DJ, van Muijen GN. The MMA1 gene family of cancer-testis antigens has multiple alternative splice variants: characterization of their expression profile, the genomic organization, and transcript properties. Genes Chromosom Cancer 2005;42:10-21.
33. Rasmussen MH, Ballarin-Gonzalez B, Liu J, Lassen LB, Fuchtbauer A, Fuchtbauer EM, et al. Antisense transcription in gammaretroviruses as a mechanism of insertional activation of host genes. J Virol 2010;84:3780-8.
34. Sokol M, Wabl M, Ruiz I, Pedersen F. Novel principles of gamma-retroviral insertional transcription activation in murine leukemia virus-induced end-stage tumors. Retrovirology 2014;11:36.
35. Minoche AE, Dohm JC, Himmelbauer H. Evaluation of genomic high-throughput sequencing data generated on Illumina HiSeq and genome analyzer systems. Genome Biol 2011;12:R112.
36. Liu L, Li Y, Li S, Hu N, He Y, Pong R, et al. Comparison of next-generation sequencing systems. J Biomed Biotechnol 2012;2012:251364.
37. Quail MA, Smith M, Coupland P, Otto TD, Harris SR, Connor TR, et al. A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers. BMC Genom 2012;13:341.
38. Moorthie S, Mattocks CJ, Wright CF. Review of massively parallel DNA sequencing technologies. HUGO J 2011;5:1-12.
39. Kircher M, Kelso J. High-throughput DNA sequencing-concepts and limitations. BioEssays 2010;32:524-36.
40. Ansorge W. Next-generation DNA sequencing techniques. N Biotechnol 2009;25:195-203.
41. Shendure J, Ji H. Next-generation DNA sequencing. Nat Biotechnol 2008;26:1135-45.
42. Visel A, Blow MJ, Li Z, Zhang T, Akiyama JA, Holt A, et al. ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 2009;457:854-8.
43. Park PJ. ChIP-seq: advantages and challenges of a maturing technology. Nat Rev Genet 2009;10:669-80.
44. Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 2010;26:589-95.
45. Trapnell C, Pachter L, Salzberg SL. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 2009;25:1105-11.
46. Team RC. R: A Language and Environment for Statistical Computing. http://wwwR-projectorg. 2013.
47. Giardine B, Riemer C, Hardison RC, Burhans R, Elnitski L, Shah P, et al. Galaxy: a platform for interactive large-scale genome analysis. Genome Res 2005;15:1451-5.
48. Thorvaldsdottir H, Robinson JT, Mesirov JP. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Briefings Bioinformat 2013;14:178-92.
49. Rosenbloom KR, Sloan CA, Malladi VS, Dreszer TR, Learned K, Kirkup VM, et al. ENCODE data in the UCSC Genome Browser: year 5 update. Nucleic Acids Res 2013;41(Database issue):D56-63.
50. Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 2010;26:841-2.
51. Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, et al. NCBI GEO: archive for functional genomics data sets-update. Nucleic Acids Res. 2013;41(Database issue):D991-5.
52. Wang XS, Prensner JR, Chen G, Cao Q, Han B, Dhanasekaran SM, et al. An integrative approach to reveal driver gene fusions from paired-end sequencing data in cancer. Nat Biotechnol 2009;27:1005-11.
53. Fullwood MJ, Wei CL, Liu ET, Ruan Y. Next-generation DNA sequencing of paired-end tags (PET) for transcriptome and genome analyses. Genome Res 2009;19:521-32.
54. Bashir A, Volik S, Collins C, Bafna V, Raphael BJ. Evaluation of paired-end sequencing strategies for detection of genome rearrangements in cancer. PLoS Comput Biol 2008;4:e1000051.
55. Yang R, Chen L, Newman S, Gandhi K, Doho G, Moreno CS, et al. Integrated analysis of whole-genome paired-end and mate-pair sequencing data for identifying genomic structural variations in multiple myeloma. Cancer Informat 2014;13(Suppl 2):49-53.
56. Rossell D, Stephan-Otto Attolini C, Kroiss M, Stocker A. Quantifying alternative splicing from paired-end Rna-sequencing data. Annals Appl Stat 2014;8:309-30.
57. Liu S, Kuang H, Lai Z. Transcriptome analysis by Illumina high-throughout paired-end sequencing reveals the complexity of differential gene expression during in vitro plantlet growth and flowering in Amaranthus tricolor L. PLoS ONE 2014;9:e100919.
58. Edgren H, Murumagi A, Kangaspeska S, Nicorici D, Hongisto V, Kleivi K, et al. Identification of fusion genes in breast cancer by paired-end RNA-sequencing. Genome Biol 2011;12:R6.
59. Medvedev P, Stanciu M, Brudno M. Computational methods for discovering structural variation with next-generation sequencing. Nat Methods 2009;6(11 Suppl):S13-20.
60. Sooknanan R, Hitchen J, Radek A, Khanna A. ScriptSeq RNA-Seq library preparation method: a simplified work-flow for directional NGS RNASeq library preparation with whole-transcript representation. J Biomol Tech 2011;22(Suppl):S40-1.
61. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009;25:1754-60.
62. Kent WJ. BLAT-the BLAST-like alignment tool. Genome Res 2002;12:656-64.
63. Schmidt M, Schwarzwaelder K, Bartholomae C, Zaoui K, Ball C, Pilz I, et al. High-resolution insertion-site analysis by linear amplification-mediated PCR (LAM-PCR). Nat Methods 2007;4:1051-7.
64. Ustek D, Sirma S, Gumus E, Arikan M, Cakiris A, Abaci N, et al. A genome-wide analysis of lentivector integration sites using targeted sequence capture and next generation sequencing technology. Infect Gen Evol 2012;12:1349-54.
65. Uren AG, Mikkers H, Kool J, van der Weyden L, Lund AH, Wilson CH, et al. A high-throughput splinkerette-PCR method for the isolation and sequencing of retroviral insertion sites. Nat Protoc 2009;4:789-98.
66. Costas J, Naveira H. Evolutionary history of the human endogenous retrovirus family ERV9. Mol Biol Evol 2000;17:320-30.
67. Shen Y, Yue F, McCleary DF, Ye Z, Edsall L, Kuan S, et al. A map of the cis-regulatory sequences in the mouse genome. Nature 2012;488:116-20.
68. Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, Steine EJ, et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci USA 2010;107:21931-6.
69. Zhang B, Day DS, Ho JW, Song L, Cao J, Christodoulou D, et al. A dynamic H3K27ac signature identifies VEGFA-stimulated endothelial enhancers and requires EP300 activity. Genome Res 2013;23:917-27.
70. Tian Y, Jia Z, Wang J, Huang Z, Tang J, Zheng Y, et al. Global mapping of H3K4me1 and H3K4me3 reveals the chromatin state-based cell type-specific gene regulation in human Treg cells. PLoS ONE 2011;6:e27770.
71. Heintzman ND, Hon GC, Hawkins RD, Kheradpour P, Stark A, Harp LF, et al. Histone modifications at human enhancers reflect global cell type-specific gene expression. Nature 2009;459:108-12.
72. Karlić R, Chung H-R, Lasserre J, Vlahoviček K, Vingron M. Histone modification levels are predictive for gene expression. Proc Natl Acad Sci USA 2010;107:2926-31.
73. Ucar D, Hu Q, Tan K. Combinatorial chromatin modification patterns in the human genome revealed by subspace clustering. Nucleic Acids Res 2011;39:4063-75.
74. Chang G, Xu S, Dhir R, Chandran U, O'Keefe DS, Greenberg NM, et al. Hypoexpression and epigenetic regulation of candidate tumor suppressor gene CADM-2 in human prostate cancer. Clin Cancer Res 2010;16:5390-401.
75. He W, Li X, Xu S, Ai J, Gong Y, Gregg JL, et al. Aberrant methylation and loss of CADM2 tumor suppressor expression is associated with human renal cell carcinoma tumor progression. Biochem Biophys Res Commun 2013;435:526-32.
76. Yang S, Yan HL, Tao QF, Yuan SX, Tang GN, Yang Y, et al. Low CADM2 expression predicts high recurrence risk of hepatocellular carcinoma patients after hepatectomy. J Cancer Res Clin Oncol 2014;140:109-16.
77. Bachelder RE, Lipscomb EA, Lin X, Wendt MA, Chadborn NH, Eickholt BJ, et al. Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells. Cancer Res 2003;63:5230-3.
78. Mishra R, Thorat D, Soundararajan G, Pradhan SJ, Chakraborty G, Lohite K, et al. Semaphorin 3A upregulates FOXO 3a-dependent MelCAM expression leading to attenuation of breast tumor growth and angiogenesis. Oncogene 2015;34:1584-95.
79. Herman JG, Meadows GG. Increased class 3 semaphorin expression modulates the invasive and adhesive properties of prostate cancer cells. Int J Oncol 2007;30:1231-8.
80. Lenz J, Celander D, Crowther RL, Patarca R, Perkins DW, Haseltine WA. Determination of the leukaemogenicity of a murine retrovirus by sequences within the long terminal repeat. Nature 1984;308:467-70.
81. DesGroseillers L, Jolicoeur P. The tandem direct repeats within the long terminal repeat of murine leukemia viruses are the primary determinant of their leukemogenic potential. J Virol 1984;52:945-52.
82. Singhal R, Deng X, Chenchik AA, Kandel ES. Long-distance effects of insertional mutagenesis. PLoS ONE 2011;6:e15832.
83. Gadalla NB, Malmberg M, Adam I, Oguike MC, Beshir K, Elzaki SE, et al. Alternatively spliced transcripts and novel pseudogenes of the Plasmodium falciparum resistance-associated locus pfcrt detected in East African malaria patients. J Antimicrob Chem 2015;70:116-23.
84. Cattoglio C, Pellin D, Rizzi E, Maruggi G, Corti G, Miselli F, et al. High-definition mapping of retroviral integration sites identifies active regulatory elements in human multipotent hematopoietic progenitors. Blood 2010;116:5507-17.
85. Ciuffi A, Barr SD. Identification of HIV integration sites in infected host genomic DNA. Methods 2011;53:39-46.
86. Arens A, Appelt JU, Bartholomae CC, Gabriel R, Paruzynski A, Gustafson D, et al. Bioinformatical clonality analysis of next generation sequencing derived viral vector integration sites. Hum Gene Therapy Met 2012;23:111-118.
87. Schopman NC, Willemsen M, Liu YP, Bradley T, van Kampen A, Baas F, et al. Deep sequencing of virus-infected cells reveals HIV-encoded small RNAs. Nucleic Acids Res 2012;40:414-27.
88. Lefebvre G, Desfarges S, Uyttebroeck F, Munoz M, Beerenwinkel N, Rougemont J, et al. Analysis of HIV-1 expression level and sense of transcription by high-throughput sequencing of the infected cell. J Virol 2011;85:6205-11.
89. Cesana D, Sgualdino J, Rudilosso L, Merella S, Naldini L, Montini E. Whole transcriptome characterization of aberrant splicing events induced by lentiviral vector integrations. J Clin Investig 2012;122:1667-76.
90. Svensson AC, Raudsepp T, Larsson C, Di Cristofano A, Chowdhary B, La Mantia G, et al. Chromosomal distribution, localization and expression of the human endogenous retrovirus ERV9. Cytogenet Cell Genet 2001;92:89-96.
91. Strazzullo M, Parisi T, Di Cristofano A, Mariano R, La Mantia G. Characterization and genomic mapping of chimeric ERV9 endogenous retroviruses-host gene transcripts1. Gene 1998;206:77-83.
92. Vincendeau M, Gottesdorfer I, Schreml JM, Wetie AG, Mayer J, Greenwood AD, et al. Modulation of human endogenous retrovirus (HERV) transcription during persistent and de novo HIV-1 infection. Retrovirology 2015;12:27.
93. Garrison KE, Jones RB, Meiklejohn DA, Anwar N, Ndhlovu LC, Chapman JM, et al. T cell responses to human endogenous retroviruses in HIV-1 infection. PLoS Pathog 2007;3:e165.
94. Assinger A, Yaiw KC, Gottesdorfer I, Leib-Mosch C, Soderberg-Naucler C. Human cytomegalovirus (HCMV) induces human endogenous retrovirus (HERV) transcription. Retrovirology 2013;10:132.
95. Nellaker C, Li F, Uhrzander F, Tyrcha J, Karlsson H. Expression profiling of repetitive elements by melting temperature analysis: variation in HERV-W gag expression across human individuals and tissues. BMC Genom 2009;10:532.
96. Li F, Nellaker C, Yolken RH, Karlsson H. A systematic evaluation of expression of HERV-W elements; influence of genomic context, viral structure and orientation. BMC Genom 2011;12:22.
97. Kunarso G, Chia N-Y, Jeyakani J, Hwang C, Lu X, Chan Y-S, et al. Transposable elements have rewired the core regulatory network of human embryonic stem cells. Nat Genet 2010;42:631-4.
98. Feschotte C. Transposable elements and the evolution of regulatory networks. Nat Rev Genet 2008;9:397-405.
99. Smit AFA, Hubley, HR, Green P. RepeatMasker Open-3.0. 1996-2010. http://www.repeatmasker.org.